CoChat

Immune and molecular correlates in melanoma treated with immune checkpoint blockade

Open access
Byrne, Elizabeth H., Fisher, David E. · 2017 · Cancer
Cited by 149

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Immunotherapy for metastatic melanoma has a decades‐long history, and the relatively recent use of checkpoint inhibitors has revolutionized treatment. Durable and sometimes complete remission of metastatic melanoma is now achievable in some patients who receive checkpoint‐blocking therapy. However, it is unclear why some patients fare better than others. This review highlights several molecular indicators of response to checkpoint inhibition in metastatic melanoma, focusing on tumor programmed death ligand 1 expression, major histocompatibility complex class I expression, mutational load in the tumor, and T‐cell infiltration into the tumor. In addition, clinical correlates of response, notably vitiligo and other immune‐related adverse events, can potentially shed light on the mechanisms by which checkpoint blockade may achieve such great success, particularly in melanoma. The authors propose that microphthalmia‐associated transcription factor—a key regulator of melanocyte survival, melanin production, and melanoma transformation—produces a molecular landscape in melanocytes and melanoma cells that can make melanomas particularly susceptible to checkpoint blockade and also can result in immune attack on normal melanocytes. Cancer 2017;123:2143‐53. © 2017 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.30444

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 149

Metadata

Authors
Byrne, E. H., & Fisher, D. E.
Venue
Cancer
Publisher
Wiley
Published
2017-05-19
Volume
123
Issue
S11
Pages
2143-2153
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2619461121
Cited by
149
References
20
FWCI
5.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune and molecular correlates in melanoma treated with immune checkpoint blockade. https://app.cochat.ai/papers/10.1002/cncr.30444
The paper
Byrne, E. H., & Fisher, D. E. (2017). Immune and molecular correlates in melanoma treated with immune checkpoint blockade. Cancer. https://doi.org/10.1002/cncr.30444

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.